Canada · Series B startup
3 rounds we have observed, with the 10 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$28Mraised across 3 rounds since 2004, from 3 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
BDC Capital
Morningside Group
Roche Venture Fund
Astellas Venture ManagementFrom a historical funding record
From a historical funding record
Reported by inimexpharma.com
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Missing a round, or an investor who was in one? Tell us.
Inimex Pharmaceuticals's investors include BDC Capital, GrowthWorks, Canadian Medical Discoveries Fund, Morningside Group and Roche Venture Fund, and 5 more on record.
Inimex Pharmaceuticals has raised $28M across 3 rounds since 2004.
Inimex Pharmaceuticals's most recent round was a Series B of $22M in Jun 2008.
Its most recent round, $22M in Jun 2008, is also its largest on record.
Inimex Pharmaceuticals's first round on record, in Jul 2004, was backed by BDC Capital, GrowthWorks and Canadian Medical Discoveries Fund.
Inimex Pharmaceuticals's latest named round is a Series B, in Jun 2008.
Inimex Pharmaceuticals is based in Canada.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
Canada · 